Search results
Heplisav-B ® (Dynavax) is a new single-antigen recombinant hepatitis B vaccine with a novel adjuvant. It is recommended for adults ≥ 18 years old and administered in two doses given ≥ 4 weeks apart.
Apr 27, 2023 · Hepatitis B vaccines are used to prevent hepatitis B, a viral infection of the liver that can lead to cirrhosis, liver failure, and liver cancer in some people. Around 850,000 people are estimated to be living with hepatitis B in the United States, 67% of whom do not realize they have been infected.
Hepatitis B vaccine is a vaccine that prevents hepatitis B. [13] The first dose is recommended within 24 hours of birth with either two or three more doses given after that. [13] This includes those with poor immune function such as from HIV/AIDS and those born premature. [13]
Mar 30, 2022 · The hepatitis B vaccine is recommended for all infants, all children or adolescents younger than 19 years of age who have not been vaccinated, all adults age 19 through 59 years, and adults age 60 years or older with risk factors for hepatitis B infection.
Aug 22, 2022 · Hepatitis B vaccines help to prevent infection caused by the Hepatitis B Virus (HBV). Hepatitis B can lead to serious liver disease, and is spread by direct contact with blood or other body fluids from an infected person.
Apr 9, 2024 · Hepatitis B can be prevented with a safe and effective vaccine. The vaccine is usually given soon after birth with boosters a few weeks later. It offers nearly 100% protection against the virus.
May 8, 2024 · Composition and dosage. The United States Food and Drug Administration (FDA) has licensed three single-antigen vaccines (Engerix-B, Heplisav-B, and Recombivax HB), one three-antigen vaccine (PreHevbrio), and three combination vaccines (Pediarix, Vaxelis, and Twinrix) to protect against hepatitis B.
